Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
116 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by Glaxo SmithKline under the trade name Relenza as a powder for oral inhalation. This report provides detailed analysis of worldwide markets for Zanamivir from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Zanamivir market and further lays out an analysis of the factors influencing the supply/demand for Zanamivir, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. GCC's report, Global Zanamivir Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Zanamivir market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Zanamivir market are Glaxo SmithKline (UK), Simcere (China), Lunan Pharmaceutical (China), among others. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Zanamivir industry has been provided.
Table of Contents Part 1. Scope of Report 1.1 Methodology 1.2 Geographic Scope 1.3 Years Considered Part 2. Introduction 2.1 Definition 2.2 Current Scenario 2.2 Future Scenario Part.3 Value Chain Analysis 3.1 Upstream 3.2 Downstream Part 4. Manufacture 4.1 Manufacturing Process 4.2 Issues and Trends 4.3 Manufacturing Costs Part 5. Worldwide Key Vendors 5.1 Company A 5.1.1 Business Overview 5.1.2 Products Offered 5.1.3 Business Performance 5.2 Company B 5.3 Company C 5.4 Company D 5.5 Company E 5.6 Company F 5.7 Company G 5.8 Company H 5.9 Company I 5.10 Company J Part 6. Market Overview 6.1 Global Production Volume 2011-2016 6.2 Production Volume by Region 2011-2016 6.2.1 North America 6.2.2 EMEA 6.2.3 Asia-Pacific 6.2.4 ROW 6.3 Global Production Value 2011-2016 6.4 Production Value by Region 6.4.1 North America 6.4.2 EMEA 6.4.3 Asia-Pacific 6.4.4 ROW Part 7. Consumption Pattern 7.1 Regional Consumption 7.1.1 North America 7.1.2 EMEA 7.1.3 Asia-Pacific 7.1.4 ROW 7.2 Global Consumption by Application Part 8. Market Forecast 8.1 Market Size by Volume 8.1.1 North America 8.1.2 EMEA 8.1.3 Asia-Pacific 8.1.4 ROW 8.2 Market Size by Value 8.2.1 North America 8.2.2 EMEA 8.2.3 Asia-Pacific 8.2.4 ROW 8.3 Regional Consumption Forecast 8.3.1 North America 8.3.2 EMEA 8.3.3 Asia-Pacific 8.3.4 ROW 8.4 Consumption Forecast by Application Part 9. Market Dynamics 9.1 Market Drivers 9.2 Market Constraints 9.3 Market Strategies Part 10. Key Events 10.1 Mergers & Acquisitions 10.2 New Product Launches 10.3 Expansions 10.4 Other Developments List of Tables and Figures Figure Global Zanamivir Production Volume (Unit) 2011-2016 Figure Global Zanamivir Production Value (M USD) 2011-2016 Figure Top 10 Zanamivir Vendors Production Volume Share 2015 Figure Top 10 Zanamivir Vendors Production Value Share 2015 Figure Regional Zanamivir Production (Unit) 2015 Figure Regional Zanamivir Production Value (M USD) 2015 Table Raw Material Materials Suppliers Figure Global Zanamivir Consumption Pattern 2015 Figure Manufacturing Cost Structure Figure Company A Zanamivir Products Table Company A Financial Performance 2011-2016 Figure Company A Market Share 2011-2016 Figure Company B Zanamivir Products Table Company B Financial Performance 2011-2016 Figure Company B Market Share 2011-2016 Figure Company C Zanamivir Products Table Company C Financial Performance 2011-2016 Figure Company C Market Share 2011-2016 Figure Company D Zanamivir Products Table Company D Financial Performance 2011-2016 Figure Company D Market Share 2011-2016 Figure Company E Zanamivir Products Table Company E Financial Performance 2011-2016 Figure Company E Market Share 2011-2016 Figure Company F Zanamivir Products Table Company F Financial Performance 2011-2016 Figure Company F Market Share 2011-2016 Figure Company G Zanamivir Products Table Company G Financial Performance 2011-2016 Figure Company G Market Share 2011-2016 Figure Company H Zanamivir Products Table Company H Financial Performance 2011-2016 Figure Company H Market Share 2011-2016 Figure Company I Zanamivir Products Table Company I Financial Performance 2011-2016 Figure Company I Market Share 2011-2016 Figure Company J Zanamivir Products Table Company J Financial Performance 2011-2016 Figure Company J Market Share 2011-2016 Table Global Key Zanamivir Vendors Production (Unit) 2011-2016 Table Global Key Zanamivir Vendors Production Share 2011-2016 Figure Global Zanamivir Capacity & Production (Unit), Capacity Utilization 2011-2016 Figure Global Top 10 Zanamivir Vendors Production (Unit) 2011-2016 Table Global Top 10 Zanamivir Vendors Production (Unit) 2011 Table Global Top 10 Zanamivir Vendors Production (Unit) 2012 Table Global Top 10 Zanamivir Vendors Production (Unit) 2013 Table Global Top 10 Zanamivir Vendors Production (Unit) 2014 Table Global Top 10 Zanamivir Vendors Production (Unit) 2015 Table Global Top 10 Zanamivir Vendors Production (Unit) 2016 Figure Zanamivir Production Volume (Unit) 2011-2016 Table Global Production Volume (Unit) 2011-2016 Table Global Production Volume Share 2011-2016 Figure North America Zanamivir Capacity & Production (Unit) Figure North America Production Share Trend Figure EMEA Zanamivir Capacity & Production (Unit) Figure EMEA Production Share Trend Figure Asia-Pacific Zanamivir Capacity & Production (Unit) Figure Asia-Pacific Production Share Trend Figure ROW Zanamivir Capacity & Production (Unit) Figure ROW Production Share Trend Change Figure Global Zanamivir Production Value (M USD), Growth Rate Table Global Key Zanamivir Vendors Production Value (M USD) 2011-2016 Table Global Key Zanamivir Vendors Production Value Share 2011-2016 Figure Global Top 10 Zanamivir Vendors Production Value (M USD) 2011-2016 Table Global Top 10 Zanamivir Vendors Production Value (M USD) 2011 Table Global Top 10 Zanamivir Vendors Production Value (M USD) 2012 Table Global Top 10 Zanamivir Vendors Production Value (M USD) 2013 Table Global Top 10 Zanamivir Vendors Production Value (M USD) 2014 Table Global Top 10 Zanamivir Vendors Production Value (M USD) 2015 Table Global Top 10 Zanamivir Vendors Production Value (M USD) 2016 Figure Zanamivir Prices (USD/Ton) 2016 Figure Zanamivir Gross Margin 2016 Figure Zanamivir Production Value (M USD) By Region 2011-2016 Table Global Zanamivir Production Value (M USD) 2011-2016 Table Global Zanamivir Production Value Share 2011-2016 Figure North America Production Value (M USD), Growth Rate Figure North America Zanamivir Production Value Share Trend Figure EMEA Production Value (M USD), Growth Rate Figure EMEA Zanamivir Production Value Share Trend Figure Asia-Pacific Production Value (M USD), Growth Rate Figure Asia-Pacific Zanamivir Production Value Share Trend Figure ROW Production Value (M USD), Growth Rate Figure ROW Zanamivir Production Value Share Trend Figure Global Zanamivir Consumption Volume (Unit) 2015 Table Regional Zanamivir Consumption Volume (Unit) 2011-2016 Table Regional Zanamivir Consumption Volume Share 2011-2016 Figure Zanamivir Consumption in North America 2011-2016 Figure Zanamivir Consumption in EMEA 2011-2016 Figure Zanamivir Consumption in Asia-Pacific 2011-2016 Figure Zanamivir Consumption in ROW 2011-2016 Figure Global Zanamivir Consumption Volume (Unit) 2016 Table Global Zanamivir Consumption Volume (Unit) 2011-2016 Table Global Zanamivir Consumption Volume Share 2011-2016 Figure Global Zanamivir Production (Unit) Forecast 2016-2021 Table Global Zanamivir Production (Unit) 2016-2021 Table Global Zanamivir Production Share 2016-2021 Figure North Zanamivir Production (Unit) Forecast 2016-2021 Figure EMEA Zanamivir Production (Unit) Forecast 2016-2021 Figure Asia-Pacific Zanamivir Production (Unit) Forecast 2016-2021 Figure ROW Zanamivir Production (Unit) Forecast 2016-2021 Figure Global Zanamivir Revenue (M USD) Forecast 2016-2021 Table Global Zanamivir Revenue (M USD) 2016-2021 Table Global Zanamivir Revenue Share 2016-2021 Figure North America Zanamivir Revenue (M USD) Forecast 2016-2021 Figure EMEA Zanamivir Revenue (M USD) Forecast 2016-2021 Figure Asia-Pacific Zanamivir Revenue (M USD) Forecast 2016-2021 Figure ROW Zanamivir Revenue (M USD) Forecast 2016-2021 Figure Global Zanamivir Consumption Volume (Unit) 2016-2021 Table Global Zanamivir Consumption Volume (Unit) 2016-2021 Table Global Zanamivir Consumption Volume Share 2016-2021 Figure North America Zanamivir Consumption (Unit) Forecast Figure EMEA Zanamivir Consumption (Unit) Forecast Figure Asia-Pacific Zanamivir Consumption (Unit) Forecast Figure ROW Zanamivir Consumption (Unit) Forecast Figure Global Zanamivir Consumption Volume (Unit) 2021 Table Global Zanamivir Consumption Volume (Unit) 2016-2021 Table Global Zanamivir Consumption Volume Share 2016-2021 Table Key Strategies for Zanamivir Multinational Corporations Table Key Strategies for Zanamivir Emerging-Market Players
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.